Gene · 4100
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current Landscape of Immunotherapy for Advanced Sarcoma. | Cancers (Basel) | 2023 | 37190214 | PubTator, text mining | PubMed |
| HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances. | Biomolecules | 2023 | 37189349 | PubTator, text mining | PubMed |
| Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer. | Cancer Immunol Res | 2023 | 37172100 | PubTator, text mining | PubMed |
| Deciphering tumor ecosystems at super resolution from spatial transcriptomics with TESLA. | Cell Syst | 2023 | 37164011 | PubTator, text mining | PubMed |
| Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1. | Oncogene | 2023 | 37161052 | PubTator, text mining | PubMed |
| Diagnostic Value of Seven Autoantibodies Combined with CEA and CA199 in Non-Small Cell Lung Cancer. | Clin Lab | 2023 | 37145062 | PubTator, text mining | PubMed |
| The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer. | Nat Cancer | 2023 | 37127787 | PubTator, text mining | PubMed |
| Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics. | Br J Cancer | 2023 | 37117649 | PubTator, text mining | PubMed |
| T Cell Based Immunotherapy for Cancer: Approaches and Strategies. | Vaccines (Basel) | 2023 | 37112747 | PubTator, text mining | PubMed |
| Molecular mimicry and cancer vaccine development. | Mol Cancer | 2023 | 37101139 | PubTator, text mining | PubMed |
| Early detection of lung cancer in a real-world cohort via tumor-associated immune autoantibody and imaging combination. | Front Oncol | 2023 | 37081975 | PubTator, text mining | PubMed |
| Identification of Cancer/Testis Antigens Related to Gastric Cancer Prognosis Based on Co-Expression Network and Integrated Transcriptome Analyses. | Adv Biomed Res | 2023 | 37057240 | PubTator, text mining | PubMed |
| Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer. | Cell Oncol (Dordr) | 2023 | 37040056 | PubTator, text mining | PubMed |
| Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects. | Vaccines (Basel) | 2023 | 36992220 | PubTator, text mining | PubMed |
| Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials. | Cancers (Basel) | 2023 | 36980692 | PubTator, text mining | PubMed |
| The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy? | Cancers (Basel) | 2023 | 36980665 | PubTator, text mining | PubMed |
| Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer. | Cells | 2023 | 36980267 | PubTator, text mining | PubMed |
| Sex-biased molecular differences in lung adenocarcinoma are ethnic and smoking specific. | BMC Pulm Med | 2023 | 36964522 | PubTator, text mining | PubMed |
| Gene-based cancer-testis antigens as prognostic indicators in hepatocellular carcinoma. | Heliyon | 2023 | 36950598 | PubTator, text mining | PubMed |
Development of novel self-assembled vaccines based on tumour-specific antigenic peptide and TLR2 agonist for effective breast cancer immunotherapy via activating CD8+ T cells and enhancing their function. | Immunology | 2023 | 36946150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4100/papers?page=7